Quantifying the Evidence for the Risk of Metabolic Syndrome and Its Components following Androgen Deprivation Therapy for Prostate Cancer: A Meta-Analysis
Background No meta-analysis is yet available for the risk of metabolic syndrome (MetS) following androgen deprivation therapy (ADT) for men with prostate cancer. To summarize the evidence for the link between ADT and MetS or its components quantitatively with a meta-analysis including all studies pu...
Uloženo v:
| Hlavní autoři: | , , , , |
|---|---|
| Médium: | Revisão |
| Jazyk: | angličtina |
| Vydáno: |
2015
|
| On-line přístup: | https://doi.org/10.1371/journal.pone.0117344 https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0117344&type=printable |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|